Globus Medical Inc (GMED)
84.72
-0.19
(-0.22%)
USD |
NYSE |
Nov 22, 16:00
84.72
0.00 (0.00%)
Pre-Market: 20:00
Globus Medical Cash from Investing (Quarterly): -14.97M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -14.97M |
June 30, 2024 | -10.38M |
March 31, 2024 | -46.58M |
December 31, 2023 | 320.62M |
September 30, 2023 | -80.86M |
June 30, 2023 | 52.22M |
March 31, 2023 | 10.99M |
December 31, 2022 | -60.48M |
September 30, 2022 | -63.11M |
June 30, 2022 | 27.13M |
March 31, 2022 | -13.89M |
December 31, 2021 | -243.80M |
September 30, 2021 | -6.885M |
June 30, 2021 | -0.143M |
March 31, 2021 | -125.11M |
December 31, 2020 | -119.09M |
September 30, 2020 | 7.661M |
June 30, 2020 | -3.299M |
March 31, 2020 | -2.592M |
December 31, 2019 | -36.04M |
September 30, 2019 | -13.67M |
June 30, 2019 | -36.74M |
March 31, 2019 | -53.84M |
December 31, 2018 | -52.62M |
September 30, 2018 | -28.86M |
Date | Value |
---|---|
June 30, 2018 | -55.43M |
March 31, 2018 | -56.11M |
December 31, 2017 | -17.37M |
September 30, 2017 | -35.15M |
June 30, 2017 | -47.83M |
March 31, 2017 | -10.93M |
December 31, 2016 | -69.59M |
September 30, 2016 | -46.21M |
June 30, 2016 | -10.81M |
March 31, 2016 | -36.12M |
December 31, 2015 | -37.91M |
September 30, 2015 | -22.84M |
June 30, 2015 | -48.52M |
March 31, 2015 | -43.78M |
December 31, 2014 | -91.43M |
September 30, 2014 | -3.774M |
June 30, 2014 | 16.18M |
March 31, 2014 | -20.98M |
December 31, 2013 | -45.91M |
September 30, 2013 | -28.13M |
June 30, 2013 | -53.16M |
March 31, 2013 | -99.96M |
December 31, 2012 | -7.652M |
September 30, 2012 | -11.21M |
June 30, 2012 | -5.536M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-243.80M
Minimum
Dec 2021
320.62M
Maximum
Dec 2023
-20.43M
Average
-12.14M
Median
Cash from Investing (Quarterly) Benchmarks
Boston Scientific Corp | -1.427B |
Haemonetics Corp | -23.37M |
ResMed Inc | 2.146M |
AngioDynamics Inc | -2.405M |
Stryker Corp | -2.172B |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 203.65M |
Cash from Financing (Quarterly) | 19.58M |
Free Cash Flow | 293.77M |
Free Cash Flow Per Share (Quarterly) | 1.171 |
Free Cash Flow to Equity (Quarterly) | 155.04M |
Free Cash Flow to Firm (Quarterly) | 162.41M |
Free Cash Flow Yield | 2.53% |